IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions
IQVIA (NYSE:IQV) announced a strategic collaboration with NVIDIA to advance AI applications in healthcare and life sciences. The partnership aims to accelerate IQVIA Healthcare-grade AI™, enabling automated workflows across therapeutic lifecycles while maintaining privacy, regulatory compliance, and patient safety standards.
The collaboration combines IQVIA's Connected Intelligence™ with NVIDIA's AI Foundry service to transform life science processes from R&D through commercialization. IQVIA will utilize NVIDIA's technology stack, including NIM microservices, NeMo, and DGX Cloud platform, with support from NVIDIA's research teams.
Initial solutions from this partnership are expected to reach the market within the calendar year. The collaboration will implement NVIDIA AI Blueprint for multi-modal data extraction, making previously inaccessible information available to AI models and agents.
IQVIA (NYSE:IQV) ha annunciato una collaborazione strategica con NVIDIA per promuovere le applicazioni di intelligenza artificiale nel settore sanitario e nelle scienze della vita. L'obiettivo della partnership è accelerare IQVIA Healthcare-grade AI™, consentendo flussi di lavoro automatizzati durante l'intero ciclo di vita terapeutico, mantenendo al contempo la privacy, la conformità normativa e gli standard di sicurezza dei pazienti.
La collaborazione unisce l'Intelligenza Connessa™ di IQVIA con il servizio AI Foundry di NVIDIA per trasformare i processi delle scienze della vita dalla ricerca e sviluppo fino alla commercializzazione. IQVIA utilizzerà la tecnologia di NVIDIA, inclusi i microservizi NIM, NeMo e la piattaforma DGX Cloud, con il supporto dei team di ricerca di NVIDIA.
Le soluzioni iniziali di questa partnership dovrebbero raggiungere il mercato entro l'anno solare. La collaborazione implementerà il NVIDIA AI Blueprint per l'estrazione di dati multimodali, rendendo disponibili a modelli e agenti di intelligenza artificiale informazioni precedentemente inaccessibili.
IQVIA (NYSE:IQV) anunció una colaboración estratégica con NVIDIA para avanzar en aplicaciones de inteligencia artificial en el cuidado de la salud y las ciencias de la vida. La asociación tiene como objetivo acelerar IQVIA Healthcare-grade AI™, permitiendo flujos de trabajo automatizados a lo largo de los ciclos de vida terapéuticos, mientras se mantienen la privacidad, el cumplimiento regulatorio y los estándares de seguridad del paciente.
La colaboración combina la Inteligencia Conectada™ de IQVIA con el servicio AI Foundry de NVIDIA para transformar los procesos de ciencias de la vida desde la I+D hasta la comercialización. IQVIA empleará la tecnología de NVIDIA, que incluye microservicios NIM, NeMo y la plataforma DGX Cloud, con el apoyo de los equipos de investigación de NVIDIA.
Se espera que las soluciones iniciales de esta asociación lleguen al mercado dentro del año calendario. La colaboración implementará el NVIDIA AI Blueprint para la extracción de datos multimodales, haciendo que información previamente inaccesible esté disponible para modelos y agentes de IA.
IQVIA (NYSE:IQV)는 NVIDIA와 전략적 협력을 발표하고 의료 및 생명 과학 분야에서 인공지능 응용 프로그램을 발전시키려 합니다. 이 파트너십의 목표는 IQVIA Healthcare-grade AI™를 가속화하여 치료 수명 주기 전반에서 자동화된 작업 흐름을 가능하게 하고, 개인 정보 보호, 규제 준수 및 환자 안전 기준을 유지하는 것입니다.
이 협력은 IQVIA의 Connected Intelligence™와 NVIDIA의 AI Foundry 서비스를 결합하여 R&D에서 상업화까지의 생명 과학 프로세스를 혁신합니다. IQVIA는 NIM 마이크로서비스, NeMo 및 DGX Cloud 플랫폼을 포함한 NVIDIA의 기술 스택을 활용하며, NVIDIA의 연구 팀의 지원을 받습니다.
이 파트너십의 초기 솔루션은 금년도 내에 시장에 출시될 것으로 예상됩니다. 이번 협力은 NVIDIA AI Blueprint를 통해 다중 모달 데이터 추출을 구현하여 이전에 접근할 수 없었던 정보를 AI 모델 및 에이전트에서 사용할 수 있도록 합니다.
IQVIA (NYSE:IQV) a annoncé une collaboration stratégique avec NVIDIA pour faire progresser les applications d'intelligence artificielle dans le domaine de la santé et des sciences de la vie. L'objectif de ce partenariat est d'accélérer IQVIA Healthcare-grade AI™, en permettant des flux de travail automatisés tout au long des cycles de vie thérapeutiques tout en maintenant la confidentialité, la conformité réglementaire et les normes de sécurité des patients.
Cette collaboration allie l'Intelligence Connue™ d'IQVIA avec le service AI Foundry de NVIDIA pour transformer les processus des sciences de la vie depuis la R&D jusqu'à la commercialisation. IQVIA utilisera la pile technologique de NVIDIA, y compris les microservices NIM, NeMo et la plateforme DGX Cloud, avec le soutien des équipes de recherche de NVIDIA.
Les premières solutions issues de ce partenariat devraient atteindre le marché dans l'année. La collaboration mettra en œuvre le NVIDIA AI Blueprint pour l'extraction de données multimodales, rendant accessibles à des modèles et agents d'intelligence artificielle des informations auparavant inaccessibles.
IQVIA (NYSE:IQV) gab eine strategische Zusammenarbeit mit NVIDIA bekannt, um KI-Anwendungen im Gesundheitswesen und in den Lebenswissenschaften voranzubringen. Ziel der Partnerschaft ist es, IQVIA Healthcare-grade AI™ zu beschleunigen und automatisierte Arbeitsabläufe über die therapeutischen Lebenszyklen hinweg zu ermöglichen, während die Privatsphäre, die gesetzlichen Vorgaben und die Sicherheitsstandards für Patienten eingehalten werden.
Die Zusammenarbeit kombiniert IQVIAs Connected Intelligence™ mit dem AI Foundry-Service von NVIDIA, um die Lebenswissenschaftsprozesse von der F&E bis zur Markteinführung zu transformieren. IQVIA wird den Technologie-Stack von NVIDIA nutzen, einschließlich NIM-Mikrodienste, NeMo und der DGX Cloud-Plattform, mit Unterstützung der Forschungsteams von NVIDIA.
Die ersten Lösungen aus dieser Partnerschaft werden voraussichtlich im laufenden Kalenderjahr auf den Markt kommen. Die Zusammenarbeit wird das NVIDIA AI Blueprint zur Erfassung multimodaler Daten implementieren, wodurch zuvor unzugängliche Informationen für KI-Modelle und -Agenten verfügbar gemacht werden.
- Strategic partnership with industry leader NVIDIA to enhance AI capabilities
- Access to NVIDIA's advanced AI technology stack and engineering support
- Initial AI solutions expected to launch within calendar year
- Potential for improved operational efficiency in healthcare processes
- None.
Insights
The IQVIA-NVIDIA collaboration marks a strategic pivot in healthcare AI implementation, leveraging NVIDIA's AI Foundry service and DGX Cloud platform to enhance IQVIA's healthcare intelligence capabilities. The integration of NVIDIA NeMo and NIM microservices represents a sophisticated technical framework that will enable the development of specialized AI agents capable of handling complex healthcare workflows. The multi-modal data extraction capability is particularly noteworthy as it will unlock previously inaccessible healthcare data formats, potentially creating new value streams from existing medical records and research data.
The partnership's technical architecture suggests a focus on developing autonomous AI agents that can operate within highly regulated healthcare environments while maintaining compliance and data privacy standards. The use of NVIDIA's AI Blueprint indicates a structured approach to scaling AI solutions across different healthcare applications, potentially reducing development cycles and implementation costs by
This partnership represents a transformative shift in healthcare operations, targeting the entire therapeutic lifecycle from R&D through commercialization. The collaboration's focus on "Healthcare-grade AI" addresses critical industry concerns about AI reliability and compliance in medical applications. By combining IQVIA's vast healthcare data assets with NVIDIA's AI capabilities, the partnership could potentially reduce drug development timelines by
The emphasis on agentic automation suggests a move toward more sophisticated AI implementations that can handle complex decision-making processes in clinical research and patient care. For investors, this positions IQVIA (IQV) at the forefront of AI-driven healthcare transformation, potentially creating new revenue streams through AI-enabled services and maintaining its competitive edge in the
From a market perspective, this collaboration significantly strengthens IQVIA's competitive position in the rapidly growing healthcare AI market, projected to reach
For investors, this represents a compelling growth catalyst for IQVIA. The company's current market cap of
The healthcare and life sciences industries generate vast amounts of data, representing significant potential for AI-powered solutions. This collaboration between IQVIA and NVIDIA will help accelerate IQVIA Healthcare-grade AI™, enabling new levels of agentic automation of complex and time-consuming workflows across the therapeutic life cycle with the precision, scalability, and trust required by IQVIA’s customers. IQVIA has been leading in the responsible use of AI, ensuring that its AI-powered capabilities are grounded in privacy, regulatory compliance, and patient safety. IQVIA Healthcare-grade AI™ represents the company’s commitment to these principles.
The collaboration will combine IQVIA’s unparalleled information assets, analytics, and domain expertise, known as IQVIA Connected Intelligence™, with the NVIDIA AI Foundry service to help transform life science processes from R&D through commercialization. This work is poised to create new efficiencies, enable new operating models, and ultimately improve patient outcomes.
"This represents a significant leap forward in how we apply AI to healthcare and life sciences," said Bhavik Patel, president, Commercial Solutions, IQVIA. "We are excited to combine our industry-leading capabilities and a decade of experience in artificial intelligence with NVIDIA’s advanced AI technologies. We will build new solutions powered by AI agents trained on world-class healthcare information and optimized for life sciences workflows. This collaboration will advance our mission to help our clients accelerate innovation and treatments to market.”
“By integrating NVIDIA AI Foundry platform and services, IQVIA can enhance its Healthcare-grade AI solutions to create custom, domain-specific models and agents for thousands of complex workflows needed in healthcare and life sciences,” said Kimberly Powell, vice president of healthcare, NVIDIA. “AI agents can become digital companions to researchers, doctors and patients, helping unlock enormous productivity and expanding access to care globally.”
IQVIA will work with NVIDIA to develop and optimize AI agents with initial solutions expected to reach market within the calendar year. The collaboration includes access to NVIDIA NIM microservices, NVIDIA NeMo and the NVIDIA DGX Cloud platform, as well as direct support from NVIDIA’s research and engineering teams. Additionally, the collaboration will be deploying the NVIDIA AI Blueprint for multi-modal data extraction to enable access to useful information previously inaccessible to AI models and agents.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250113713508/en/
Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)
+1.973.541.3558
Alissa Maupin, IQVIA Media Relations (alissa.maupin1@iqvia.com)
+1.919.923.6785
Source: IQVIA
FAQ
What is the purpose of IQVIA's collaboration with NVIDIA?
When will IQVIA (IQV) launch its first AI solutions from the NVIDIA partnership?
What technologies will IQVIA (IQV) gain access to through the NVIDIA partnership?
How will the IQVIA-NVIDIA collaboration improve healthcare data processing?
What is IQVIA Healthcare-grade AI™ and how will it benefit from NVIDIA?
